(Q48366358)

English

Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure

scientific article published in March 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Usefulness of brain natriuretic peptide release as a surrogate marker of the efficacy of long-term cardiac resynchronization therapy in patients with heart failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

0 references

author name string

Anil-Martin Sinha

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Karsten Filzmaier

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Ole-Alexander Breithardt

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Dagmar Kunz

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Jürgen Graf

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Kai U Markus

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Peter Hanrath

7

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Christoph Stellbrink

8

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

language of work or name

0 references

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

91

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

755-758

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Intraventricular conduction delay and functional mitral regurgitation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903425-2

7 January 2021

Identifiers

10.1016/S0002-9149(02)03425-2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/12633819

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48366358&oldid=2195956671"